17:40 – 17:43 Welcome Adie Viljoen (UK) 17:43 – 17:51 Early treatment: what are the benefits of early initiation of GLP-1RAs? Tina Vilsbøll (DNK)Juris Meier
19:00 – 19:02 The incretin effect revisited Tina Vilsbøll (DNK) 19:02 – 19:05 Physiological effect of GIP Juris Meier (GER) 19:05 – 19:07 GIP effects
SUPPPORT STATEMENTSupported by an independent educational grant from Lilly 08:15 – 08:25 Better Metabolic Health with Incretin-based Therapies – Achievements and Ambitions Michael Nauck (GER)
MORE INFORMATION HERE 18:45 – 19:00 Subtype Classification of T2D: Are We There Yet? Hertzel Gerstein (CAN) 19:00 – 19:15 Live Q&A Hertzel Gerstein (CAN)
